These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7653146)

  • 41. [Immunobiological properties of Bordetella pertussis lipopolysaccharide in the acellular pertussis vaccine].
    Zaĭtsev EM; Poddubikov AV; Britsina MV; Mertsalova NU; Ozeretskovskaia MN; Bazhanova IG; Plekhanova NG
    Zh Mikrobiol Epidemiol Immunobiol; 2014; (1):20-4. PubMed ID: 24738289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fimbrial hemagglutinin in stationary and shake cultures of Bordetella pertussis.
    Arai H; Munoz JJ
    Infect Immun; 1979 Aug; 25(2):764-7. PubMed ID: 39897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Release of lipopolysaccharide during Bordetella pertussis growth.
    Hozbor D; Rodriguez ME; Samo A; Lagares A; Yantorno O
    Res Microbiol; 1993; 144(3):201-9. PubMed ID: 8210677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunochemical study of the antigenic structure of bacteria of genus Bordetella. IV. Fractionation of B. pertussis extracts and study of the immunochemical and biological properties of the isolated fractions].
    Samsonova VS; Kholchev NV; Mamaeva EA; Kuznetsova LS; Shnaĭder GV
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):73-8. PubMed ID: 50683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surface antigens of Bordetella pertussis.
    Parker CD; Armstrong SK; Frank DW
    Adv Exp Med Biol; 1985; 185():117-27. PubMed ID: 2866677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.
    Novotny P; Chubb AP; Cownley K; Montaraz JA; Beesley JE
    Dev Biol Stand; 1985; 61():27-41. PubMed ID: 2872113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Purification of pertussis toxin.
    Perera VY
    Methods Enzymol; 1988; 165():120-6. PubMed ID: 2906727
    [No Abstract]   [Full Text] [Related]  

  • 49. [Physico-chemical and serological study of agglutinogen 3 of B. pertussis].
    Amelina IP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Feb; (2):64-7. PubMed ID: 178126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor].
    Siundiukova RA; Basnak'ian IA; Stukalova NV; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):14-7. PubMed ID: 10876840
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunochemical study of the antigenic structure of Bordetella genus bacteria. I. Immunoelectrophoretic analysis of the antigenic structure of different strains of Bordetella pertussis and their biological properties].
    Samsonova VS; Kolchev NV; Shed'ko NN; Kondrat'eva AM; Mamaeva EA
    Zh Mikrobiol Epidemiol Immunobiol; 1971; 48(6):17-22. PubMed ID: 4328259
    [No Abstract]   [Full Text] [Related]  

  • 52. Antimicrobial effect of human milk on Bordetella pertussis.
    Redhead K; Hill T; Mulloy B
    FEMS Microbiol Lett; 1990 Aug; 58(3):269-73. PubMed ID: 2227362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Bordetella pertussis agglutinogens in cultivation dynamics].
    Basnak'ian IA; Aleksakhina NN; Shelemekh OV; Miriasova LV; Siundiukova RA
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (3):37-42. PubMed ID: 17672129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis.
    Wardlaw AC; Parton R; Hooker MJ
    J Med Microbiol; 1976 Feb; 9(1):89-100. PubMed ID: 57240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extracytoplasmic adenylate cyclase of Bordetella pertussis.
    Hewlett EL; Urban MA; Manclark CR; Wolff J
    Proc Natl Acad Sci U S A; 1976 Jun; 73(6):1926-30. PubMed ID: 180529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of Bordetella pertussis suspensions by ELISA and flow cytometry.
    Jiskoot W; Westdijk J; Reubsaet CH; Beuvery EC
    Adv Exp Med Biol; 1996; 397():153-7. PubMed ID: 8718594
    [No Abstract]   [Full Text] [Related]  

  • 57. Improved pertussis toxin production by Bordetella pertussis through adjusting the growth medium's ionic composition.
    Frohlich BT; De Bernardez Clark ER; Siber GR; Swartz RW
    J Biotechnol; 1995 May; 39(3):205-19. PubMed ID: 7766402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective activity of Bordetella adenylate cyclase-hemolysin against bacterial colonization.
    Guiso N; Szatanik M; Rocancourt M
    Microb Pathog; 1991 Dec; 11(6):423-31. PubMed ID: 1795632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pertussis toxin and cross-reactive antigens in dynamics of Bordetella pertussis cultivation].
    Basnak'ian IA; Aleksakhina NN; Siundiukova SA; Zakharova NS; Zaĭtsev EM; Iastrebova NE; Vaneeva NP
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (5):54-7. PubMed ID: 18038548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Characteristics of the biological properties of a cell-free pertussis preparation].
    Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MN; Shmeleva EI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):38-43. PubMed ID: 2888247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.